MabVax Therapeutics, Inc. Receives SBIR Program Award From the National Cancer Institute to Manufacture Clinical Supplies for Phase 2 Neuroblastoma Trial
12/18/2012 8:47:55 AM
More...
|
MabVax Therapeutics, Inc. Raises $5.25 Million
11/20/2012 8:30:21 AM
More...
|
MabVax Therapeutics, Inc. Receives $1.8 Million in a Phase 2 Small Business Innovation Research Program Award From the National Cancer Institute
4/11/2011 7:47:04 AM
More...
|
MabVax Therapeutics, Inc. Receives Small Business Innovation Research Program Award from the National Cancer Institute
8/17/2010 8:56:55 AM
More...
|
MabVax Therapeutics, Inc. Receives $1.1 Million Phase 2 Small Business Technology Transfer Program Award From The National Cancer Institute
8/11/2010 8:09:48 AM
More...
|
MabVax Therapeutics, Inc. Initiates Phase II Clinical Trial of Vaccine to Prevent Recurrent Sarcoma
7/22/2010 9:19:59 AM
More...
|
MabVax Therapeutics, Inc. Closes Two Licensing Agreements With Sloan-Kettering Institute for Cancer Research
8/12/2008 9:25:23 AM
More...
|